Impact of serous fluid volume on next-generation sequencing: a significant step forward for optimization of serous fluid sample collection
- 3 July 2024
- journal article
- research article
- Published by Elsevier in Journal of the American Society of Cytopathology
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Optimal fluid volume for detecting malignancy in serous effusions: a single institution experienceJournal of the American Society of Cytopathology, 2023
- Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathologyActa Neuropathologica Communications, 2022
- Reassessing the optimal volume for malignancy detection in serous fluid cytologyCancer Cytopathology, 2022
- The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective studyEuropean Clinical Respiratory Journal, 2021
- Current applications of molecular testing on body cavity fluidsDiagnostic Cytopathology, 2020
- Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literatureDiagnostic Cytopathology, 2019
- Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimensCancer Cytopathology, 2019
- Yield of Malignant Pleural Effusion for Detection of Oncogenic Driver Mutations in Lung AdenocarcinomaJournal of Bronchology & Interventional Pulmonology, 2019
- Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimensJournal of Thoracic Disease, 2018
- A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial EffusionsAmerican Journal of Clinical Pathology, 2015